Choosing between Amgen (NASDAQ: AMGN) and Bristol Myers Squibb (NYSE: BMY) requires balancing growth potential against value-oriented income.
POLARIS INSIGHTS
POLARIS INSIGHTS
Choosing between Amgen (NASDAQ: AMGN) and Bristol Myers Squibb (NYSE: BMY) requires balancing growth potential against value-oriented income.